CEO and President of $CRWV sells 5,704 shares in insider sale

The recent sale of 5,704 shares of $CRWV by Michael N Intrator, the CEO and President, has caught the eye of investors and analysts alike. The sale, which took place on 08-27-2025, amounted to an estimated $536,918, representing approximately 13.0% of their shares in this stock class. Following this transaction, Intrator now holds 38,279 shares of $CRWV stock.

Over the past 6 months, insiders at $CRWV have been actively trading the company’s stock. In a total of 134 transactions, 3 were purchases, while 131 were sales. Notable figures include Jack D Cogen, who made 11 sales totaling 4,220,760 shares, Financial LLC Magnetar with 48 sales of 2,401,136 shares, and Brannin McBee, the Chief Development Officer, who sold 1,250,000 shares in 26 transactions. Other key insiders, such as Kristen J McVeety, Brian M Venturo, and Michael N Intrator, have also been actively involved in selling off portions of their shares.

The market sentiment surrounding $CRWV has been captured through analyst ratings, with 9 firms advocating for buying the stock and 2 suggesting sell positions. Recent analyst ratings include an “Overweight” rating from Cantor Fitzgerald, a “Buy” rating from HC Wainwright & Co., and a “Buy” rating from Argus Research. Citigroup, Northland Capital Markets, HSBC, and DA Davidson have all issued their own ratings as well, providing a comprehensive overview of the stock’s standing in the eyes of analysts.

Additionally, analysts have set price targets for $CRWV, with 21 analysts offering targets in the last 6 months, leading to a median target of $115.0. Thomas Blakey from Cantor Fitzgerald set a target price of $116.0, Kevin Dede from HC Wainwright & Co. at $180.0, and Nick Del Deo from MoffettNathanson at $65.0. Other analysts, such as those from Argus Research, Stifel, B of A Securities, and Macquarie, have provided their own price targets, each contributing to the overall range of predictions for $CRWV’s stock performance in the future.

It is important to note that the information provided in this article is intended for informational purposes only and should not be considered financial advice. Investors are encouraged to conduct their own research and due diligence before making any investment decisions.